Published in Inflamm Bowel Dis on September 01, 2010
A Pilot Study of Allopurinol As A Modifier of 6-MP Metabolism in Pediatric ALL | NCT02046694
Current and emerging drugs for the treatment of inflammatory bowel disease. Drug Des Devel Ther (2011) 1.52
Optimization of conventional therapy in patients with IBD. Nat Rev Gastroenterol Hepatol (2011) 0.92
Use of thiopurines in inflammatory bowel disease. World J Gastroenterol (2013) 0.89
Optimizing 6-mercaptopurine and azathioprine therapy in the management of inflammatory bowel disease. World J Gastroenterol (2011) 0.82
Hematologic indices as surrogate markers for monitoring thiopurine therapy in IBD. Dig Dis Sci (2014) 0.80
Thiopurine monitoring in children with inflammatory bowel disease: a systematic review. Br J Clin Pharmacol (2014) 0.79
Clinical predictors of thiopurine-related adverse events in Crohn's disease. World J Gastroenterol (2015) 0.78
Current status of thiopurine analogues in the treatment in Crohn's disease. World J Gastroenterol (2011) 0.78
Therapeutic drug monitoring in inflammatory bowel disease. Ann Gastroenterol (2014) 0.77
Low-dose azathioprine is effective in maintaining remission in steroid-dependent ulcerative colitis: results from a territory-wide Chinese population-based IBD registry. Therap Adv Gastroenterol (2016) 0.77
Safety and efficacy of the immunosuppressive agent 6-tioguanine in murine model of acute and chronic colitis. BMC Gastroenterol (2011) 0.76
Two brothers with skewed thiopurine metabolism in ulcerative colitis treated successfully with allopurinol and mercaptopurine dose reduction. Dig Dis Sci (2011) 0.76
Efficacy of thioguanine treatment in inflammatory bowel disease: A systematic review. World J Gastroenterol (2016) 0.75
Combination treatment with 6-mercaptopurine and allopurinol in HepG2 and HEK293 cells - Effects on gene expression levels and thiopurine metabolism. PLoS One (2017) 0.75
Biotransformation of 6-thioguanine in inflammatory bowel disease patients: a comparison of oral and intravenous administration of 6-thioguanine. Br J Pharmacol (2011) 0.75
Co-existence of Crohn's disease, sarcoidosis and malignant lymphomas. JRSM Short Rep (2012) 0.75
New genetic biomarkers predicting azathioprine blood concentrations in combination therapy with 5-aminosalicylic acid. PLoS One (2014) 0.75
Safety Profile of Thiopurines in Crohn Disease: Analysis of 893 Patient-Years Follow-Up in a Southern China Cohort. Medicine (Baltimore) (2015) 0.75
Thiopurines and inflammatory bowel disease: Current evidence and a historical perspective. World J Gastroenterol (2016) 0.75
Endoscopy Assessment at 1-Year Identifies Long-Term Responders to Thiopurines Maintenance Therapy in Patients With Crohn's Disease. Medicine (Baltimore) (2015) 0.75
Prospective Evaluation of Pharmacogenomics and Metabolite Measurements upon Azathioprine Therapy in Inflammatory Bowel Disease: An Observational Study. Medicine (Baltimore) (2016) 0.75
Thiopurine metabolites variations during co-treatment with aminosalicylates for inflammatory bowel disease: effect of N-acetyl transferase polymorphisms. World J Gastroenterol (2015) 0.75
Auto immune hepatitis. World J Gastroenterol (2016) 0.75
Hepatic complications induced by immunosuppressants and biologics in inflammatory bowel disease. World J Hepatol (2017) 0.75
More Dose-dependent Side Effects with Mercaptopurine over Azathioprine in IBD Treatment Due to Relatively Higher Dosing. Inflamm Bowel Dis (2017) 0.75
Monitoring thiopurine metabolites in inflammatory bowel disease. Frontline Gastroenterol (2016) 0.75
High frequency of early colorectal cancer in inflammatory bowel disease. Gut (2008) 3.46
Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. Gut (2009) 2.50
Serum I-FABP as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodies. Aliment Pharmacol Ther (2013) 2.20
Guidelines for treatment with infliximab for Crohn's disease. Neth J Med (2006) 2.10
Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort. Gut (2008) 2.06
Allopurinol safely and effectively optimises thiopurine metabolites in patients with autoimmune hepatitis. Aliment Pharmacol Ther (2013) 2.03
The use of prophylactic gastroprotective therapy in patients with nonsteroidal anti-inflammatory drug- and aspirin-associated ulcer bleeding: a cross-sectional study. Aliment Pharmacol Ther (2013) 2.02
Circulating V(alpha24+) Vbeta11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage. Clin Immunol (2001) 1.94
Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience. Gut (2007) 1.92
Disappointing outcome of autologous stem cell transplantation for enteropathy-associated T-cell lymphoma. Dig Liver Dis (2007) 1.79
Aberrant T-lymphocytes in refractory coeliac disease are not strictly confined to a small intestinal intraepithelial localization. Cytometry B Clin Cytom (2009) 1.56
Recurrent acute biliary pancreatitis: the protective role of cholecystectomy and endoscopic sphincterotomy. Surg Endosc (2009) 1.55
Tioguanine in the treatment of refractory coeliac disease--a single centre experience. Aliment Pharmacol Ther (2012) 1.48
[Periodic fever due to hyper-IgD syndrome]. Ned Tijdschr Geneeskd (2000) 1.48
[Palliative treatment of esophageal cancer with dysphagia: more favourable outcome from single-dose internal brachytherapy than from the placement of a self-expanding stent; a multicenter randomised study]. Ned Tijdschr Geneeskd (2005) 1.48
Azathioprine and prednisone combination therapy in refractory coeliac disease. Aliment Pharmacol Ther (2003) 1.28
Diverticulosis and diverticulitis form no risk for polyps and colorectal neoplasia in 4,241 colonoscopies. Int J Colorectal Dis (2008) 1.19
IS-pro: high-throughput molecular fingerprinting of the intestinal microbiota. FASEB J (2010) 1.13
Colonoscopy-controlled intra-individual comparisons to screen relevant neoplasia: faecal immunochemical test vs. guaiac-based faecal occult blood test. Aliment Pharmacol Ther (2009) 1.10
Hemostatic imbalance in active and quiescent ulcerative colitis. Am J Gastroenterol (2001) 1.09
Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population. Gut (2002) 1.08
Letter: volatile metabolomics of exhaled breath or faecal gas? Aliment Pharmacol Ther (2015) 1.06
A microarray screen for novel candidate genes in coeliac disease pathogenesis. Gut (2004) 1.02
The management of complicated celiac disease. Dig Dis (2007) 1.01
Risk of malignant lymphoma in patients with inflammatory bowel diseases: a Dutch nationwide study. Inflamm Bowel Dis (2010) 1.00
A NFKB1 promoter polymorphism is involved in susceptibility to ulcerative colitis. Int J Immunogenet (2005) 0.98
The citrulline generation test: proposal for a new enterocyte function test. Aliment Pharmacol Ther (2008) 0.97
Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease. Br J Cancer (2009) 0.96
Description of a novel grading system to assess the quality of bowel preparation in video capsule endoscopy. Endoscopy (2011) 0.95
Coeliac disease: changing views on gluten-sensitive enteropathy. Scand J Gastroenterol Suppl (2002) 0.95
Coeliac disease and (extra)intestinal T-cell lymphomas: definition, diagnosis and treatment. Scand J Gastroenterol Suppl (2004) 0.95
Auto-SCT in refractory celiac disease type II patients unresponsive to cladribine therapy. Bone Marrow Transplant (2010) 0.95
Splenic rupture following colonoscopy, a rare complication. Neth J Med (2009) 0.95
Long-term follow-up of children exposed intrauterine to maternal thiopurine therapy during pregnancy in females with inflammatory bowel disease. Aliment Pharmacol Ther (2013) 0.94
Diagnosis and treatment of (disease-related) in-hospital malnutrition: the performance of medical and nursing staff. Clin Nutr (2008) 0.92
Dutch endoscopic capacity in the era of colorectal cancer screening. Neth J Med (2006) 0.91
Myelotoxicity and hepatotoxicity during azathioprine therapy. Neth J Med (2005) 0.91
The effect of NOD2 activation on TLR2-mediated cytokine responses is dependent on activation dose and NOD2 genotype. Genes Immun (2008) 0.89
Safety of thiopurines in the treatment of inflammatory bowel disease. Scand J Gastroenterol Suppl (2003) 0.87
Thiopurines in inflammatory bowel disease: pharmacogenetics, therapeutic drug monitoring and clinical recommendations. Dig Liver Dis (2005) 0.87
Absence of nodular regenerative hyperplasia after low-dose 6-thioguanine maintenance therapy in inflammatory bowel disease patients. Dig Liver Dis (2007) 0.86
Predictive value of inflammatory and coagulation parameters in the course of severe ulcerative colitis. Dig Dis Sci (2001) 0.85
Distribution of peroxisome proliferator-activated receptor-gamma polymorphisms in Chinese and Dutch patients with inflammatory bowel disease. Inflamm Bowel Dis (2010) 0.85
Milestone in gastrointestinal endoscopy: double-balloon enteroscopy of the small bowel. Scand J Gastroenterol Suppl (2006) 0.84
Signal transducer and activator of transcription 6 gene G2964A polymorphism and inflammatory bowel disease. Clin Exp Immunol (2003) 0.84
Influence of 5-aminosalicylic acid on 6-thioguanosine phosphate metabolite levels: a prospective study in patients under steady thiopurine therapy. Br J Pharmacol (2010) 0.84
Small bowel adenocarcinoma copy number profiles are more closely related to colorectal than to gastric cancers. Ann Oncol (2011) 0.83
Chemoprevention for colon cancer: new opportunities, fact or fiction? Scand J Gastroenterol Suppl (2006) 0.82
More right-sided IBD-associated colorectal cancer in patients with primary sclerosing cholangitis. Inflamm Bowel Dis (2009) 0.82
Anti-calreticulin immunoglobulin A (IgA) antibodies in refractory coeliac disease. Clin Exp Immunol (2008) 0.82
Assessment of small bowel function in critical illness: potential role of citrulline metabolism. J Intensive Care Med (2011) 0.82
The effect of allopurinol and low-dose thiopurine combination therapy on the activity of three pivotal thiopurine metabolizing enzymes: results from a prospective pharmacological study. J Crohns Colitis (2013) 0.82
Elastic band ligation of hemorrhoids: flexible gastroscope or rigid proctoscope? World J Gastroenterol (2007) 0.81
Listeria monocytogenes and inflammatory bowel disease: detection of Listeria species in intestinal mucosal biopsies by real-time PCR. Scand J Gastroenterol (2003) 0.81
Are malnourished patients complex patients? Health status and care complexity of malnourished patients detected by the Short Nutritional Assessment Questionnaire (SNAQ). Eur J Intern Med (2006) 0.81
Thalidomide in refractory haemorrhagic radiation induced proctitis. Gut (2006) 0.80
Safe use of allopurinol and low-dose mercaptopurine therapy during pregnancy in an ulcerative colitis patient. Inflamm Bowel Dis (2013) 0.80
Rheumatology meets hepatology in 2012: a clinician's guideline for TNF inhibitors in hepatitis B/C virus carriers. Expert Opin Biol Ther (2012) 0.80
On attitudes about colorectal cancer screening among gastrointestinal specialists and general practitioners in the Netherlands. World J Gastroenterol (2006) 0.80
Celiac disease. Gastroenterol Res Pract (2012) 0.80
Limited stability of thiopurine metabolites in blood samples: relevant in research and clinical practise. J Chromatogr B Analyt Technol Biomed Life Sci (2010) 0.79
Optimal strategies to identify aberrant intra-epithelial lymphocytes in refractory coeliac disease. J Clin Immunol (2014) 0.79
Accurate classification of RCD requires flow cytometry. Gut (2010) 0.79
Primary herpes simplex type 1 esophagitis followed by recurrent perianal herpetic infection in an immunocompetent host. Am J Gastroenterol (2009) 0.78
Serum eosinophil cationic protein in active and quiescent ulcerative colitis. Clin Chem Lab Med (2000) 0.78
Review article: Stem cell transplantation for the treatment of gastrointestinal diseases--current applications and future perspectives. Aliment Pharmacol Ther (2007) 0.78
[Energy losses from a short bowel: not only fat]. Ned Tijdschr Geneeskd (2005) 0.78
Long-term follow-up of two patients with metastatic neuroendocrine tumours treated with octreotide. Neth J Med (1998) 0.77
Azathioprine or mercaptopurine-induced acute pancreatitis is not a disease-specific phenomenon. Aliment Pharmacol Ther (2010) 0.77
Critical reappraisal of anorectal function tests in patients with faecal incontinence who have failed conservative treatment. Int J Colorectal Dis (2012) 0.77
Celiac disease is not yet mainstream in endoscopy. Endoscopy (2010) 0.77
Thiopurine treatment in patients with Crohn's disease leads to a selective reduction of an effector cytotoxic gene expression signature revealed by whole-genome expression profiling. Mol Immunol (2013) 0.77
Mesalazine is safe for the treatment of IBD. Gut (2004) 0.77
Letter: allopurinol co-therapy is safe and effective in autoimmune hepatitis -- authors' reply. Aliment Pharmacol Ther (2013) 0.77
On the limitation of 6-tioguaninenucleotide monitoring during tioguanine treatment. Aliment Pharmacol Ther (2005) 0.77